WASHINGTON—Federal regulators on Wednesday issued new recommendations on drug-induced abortions that may make it easier for women in some states to obtain the procedure, a move that comes at a particularly charged moment in the national debate. The Food and Drug Administration said it would change the label for mifepristone, the main pill used in the procedure, in a way that would effectively sidestep state laws aimed at restricting drug-induced abortion. While FDA guidelines for the use of drugs aren’t binding, a...
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now